How ResMed Blew Past Expectations With Its Q1 Results
Despite a horrible start, 2019 has turned out to be a reasonably good year so far for ResMed (NYSE: RMD). The healthcare company has consistently beaten Wall Street earnings estimates in recent quarters and delivered solid growth.
ResMed announced its fiscal 2020 first-quarter results after the market closed on Thursday, and the company kept its streak going with more good news. Here are the highlights from ResMed's Q1 update.
Image Source: Getty Images.
Source Fool.com
